Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

SZSE:300937 Stock Report

Market Cap: CN¥3.0b

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Past Earnings Performance

Past criteria checks 0/6

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's earnings have been declining at an average annual rate of -4.4%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 14.2% per year. Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's return on equity is 2.1%, and it has net margins of 0.5%.

Key information

-4.4%

Earnings growth rate

-14.1%

EPS growth rate

Consumer Retailing Industry Growth12.8%
Revenue growth rate14.2%
Return on equity2.1%
Net Margin0.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality

Apr 17
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality

Recent updates

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce

Nov 12
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce

Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal

Sep 27
Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal

Returns On Capital At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Paint A Concerning Picture

Jun 07
Returns On Capital At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Paint A Concerning Picture

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality

Apr 17
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality

Revenue & Expenses Breakdown

How Sichuan Hezong Medicine Easy-to-buy Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300937 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,4542329518
30 Jun 244,4512527519
31 Mar 244,5463727019
31 Dec 234,4306025719
30 Sep 234,4997527219
30 Jun 234,4168126218
31 Mar 234,1816524817
01 Jan 233,9694222418
30 Sep 223,6771219124
30 Jun 223,565517720
31 Mar 223,4801416016
01 Jan 223,401616511
30 Sep 213,172331400
30 Jun 213,049401360
31 Mar 212,917451360
31 Dec 202,790541270
30 Sep 202,689692440
31 Dec 192,289651250
31 Dec 182,02457970
31 Dec 171,58745850
31 Dec 161,24129620

Quality Earnings: 300937 has a large one-off gain of CN¥8.7M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 300937's current net profit margins (0.5%) are lower than last year (1.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300937's earnings have declined by 4.4% per year over the past 5 years.

Accelerating Growth: 300937's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300937 had negative earnings growth (-69.1%) over the past year, making it difficult to compare to the Consumer Retailing industry average (6%).


Return on Equity

High ROE: 300937's Return on Equity (2.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies